Tests to predict responsiveness of cancer patients to...

Details Tests to predict responsiveness of cancer patients to... Tests to predict responsiveness of cancer patients to...

C - Chemistry, Metallurgy

12

Q

C12Q 1/68 (2006.01) C40B 30/04 (2006.01) C40B 40/06 (2006.01)

Patent

CA 2723972

The present disclosure provides methods and compositions to facilitate prediction of the likelihood of responsiveness of cancer patients to treatment including a taxane and/or a cyclophosphamide.

La présente invention porte sur des procédés et des compositions pour faciliter la prédiction de la probabilité de sensibilité de patients atteints de cancer à un traitement comprenant un taxane et/ou un cyclophosphamide.

Affiliated with

Also associated with

Rating

Tests to predict responsiveness of cancer patients to... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tests to predict responsiveness of cancer patients to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tests to predict responsiveness of cancer patients to... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1748518